• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Afatinib
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    Boehringer Ingelheim
    partial basket chart

    Protein Kinase Inhibitor. Afatinib (as dimaleate) 20, 30, 40, 50 mg.
    F.C TABS: 7, 14, 28 × 20 mg, 30 mg, 40
    mg, 50 mg.
    40 mg 1 x dly., 3 hrs. before meal and at
    least 1 h. after. May incr. up to 50 mg 1 x
    dly after 3 wks. without serious adverse
    events. Tmt. should be cont. until dis.
    progres. or until no longer tolerat. By
    the pt. see lit.
    As monother. for the tmt. of: EGFR TKInaïve
    adult pts. with local. advanc. or
    metastat. NSCLC with activat. EGFR
    mutation(s); Local. advance. or metast.
    NSCLC of squamous histology progress. on
    or after platin. -based chemother.
    C/I: Hypersens., pregnancy, lact.